We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

574 hedge funds and large institutions have $2.36B invested in iShares US Medical Devices ETF in 2023 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 138 increasing their positions, 245 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $43M | Put options by funds: $20.4M

68% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 56

18% more capital invested

Capital invested by funds: $2.01B → $2.36B (+$353M)

6% more funds holding

Funds holding: 544574 (+30)

4.42% more ownership

Funds ownership: 39.49%43.91% (+4.4%)

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

44% less repeat investments, than reductions

Existing positions increased: 138 | Existing positions reduced: 245

Holders
574
Holders Change
+30
Holders Change %
+5.51%
% of All Funds
8.37%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
94
Increased
138
Reduced
245
Closed
56
Calls
$43M
Puts
$20.4M
Net Calls
+$22.6M
Net Calls Change
+$16.7M
Name Holding Trade Value Shares
Change
Change in
Stake
HWM
401
Howard Wealth Management
Connecticut
$222K -$57.6K -1,180 -22%
WANY
402
Wealthspire Advisors (New York)
New York
$218K +$197K +4,041 New
SFI
403
SPC Financial Inc
Maryland
$216K -$36.6K -750 -16%
MW
404
Marcum Wealth
Ohio
$215K -$8.21K -168 -4%
KeyBank National Association
405
KeyBank National Association
Ohio
$214K +$193K +3,959 New
KWS
406
Keystone Wealth Services
California
$213K +$193K +3,955 New
TCM
407
Tufton Capital Management
Maryland
$212K +$192K +3,925 New
WWM
408
Western Wealth Management
Colorado
$210K +$191K +3,900 New
TW
409
TrinityPoint Wealth
Connecticut
$210K +$190K +3,890 New
ANTB
410
AMG National Trust Bank
Colorado
$210K +$190K +3,888 New
SPW
411
Sonoma Private Wealth
California
$209K +$190K +3,880 New
CT
412
Colonial Trust
South Carolina
$208K +$89.7K +1,836 +91%
JSC
413
Jackson Square Capital
California
$205K +$185K +3,792 New
SRSA
414
S.R. Schill & Associates
Washington
$204K +$185K +3,780 New
PWS
415
Peterson Wealth Services
Utah
$203K +$184K +3,766 New
MCIA
416
Mountain Capital Investment Advisors
Colorado
$203K +$182K +3,723 New
BBWP
417
Beacon Bridge Wealth Partners
Pennsylvania
$202K -$51.4K -1,052 -22%
CCA
418
Cadent Capital Advisors
Oklahoma
$201K +$182K +3,720 New
AWE
419
Avidian Wealth Enterprises
Texas
$201K +$182K +3,716 New
SIC
420
Salem Investment Counselors
North Carolina
$196K +$977 +20 +0.6%
CT
421
Clearstead Trust
Maine
$183K
LFG
422
Larson Financial Group
Missouri
$183K +$10.7K +220 +7%
AWM
423
Activest Wealth Management
Florida
$178K +$244 +5 +0.2%
MWM
424
MGB Wealth Management
Texas
$163K +$148K +3,024 New
NFSG
425
Newbridge Financial Services Group
Florida
$162K -$86.6K -1,773 -37%

IHI Hedge Fund Activity: Q4 2023 in Review

574 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2023, worth a combined $2.36B — up 18% from $2.01B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new IHI positions and 56 closed out — a net gain of 38 holders — while 138 added to existing stakes and 245 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $159M. The largest seller was Bank of America, cutting an estimated $25.1M.

  • 574 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2023, up from 544 in Q3 2023.
  • Funds reported $2.36B of iShares US Medical Devices ETF stock for Q4 2023, up 18% quarter-over-quarter.
  • 94 funds opened new iShares US Medical Devices ETF positions in Q4 2023 and 56 closed out, a net change of +38 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2023 was Morgan Stanley, an estimated $159M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2023 was Bank of America, an estimated $25.1M sold.

Based on aggregated 13F filings for Q4 2023.